Thromboxane A2
Thromboxane A2 - Related Videos
07:00
A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
0 Views •
2019
In the present study, we describe a methodology to analyze the C924T genotype. The protocol consists of three phases: DNA extraction, amplification by polymerase chain reaction (PCR), and analysis of the restriction fragment length polymorphism (RFLP) on agarose gel.
07:11
Dissipative Microgravimetry to Study the Binding Dynamics of the Phospholipid Binding Protein Annexin A2 to Solid-supported Lipid Bilayers Using a Quartz Resonator
0 Views •
Cited by 5 •
2018
Here, we present an experimental protocol that can be employed to determine the binding affinities and mode of interaction of label-free phospholipid-binding protein annexin A2 with immobilized solid-supported bilayers (SLB) by simultaneously measuring the mass uptake and the viscoelastic properties of the protein annexin A2.
09:49
Isolation and Cannulation of Cerebral Parenchymal Arterioles
0 Views •
Cited by 28 •
2016
This manuscript describes a simple and reproducible protocol for isolation of intracerebral arterioles (a group of blood vessels encompassing parenchymal arterioles, penetrating arterioles and pre-capillary arterioles) from mice, to be used in pressure myography, immunofluorescence, biochemistry, and molecular studies.
03:38
Polyprotic Acids
0 Views •
2020
Acids are classified by the number of protons per molecule that they can give up in a reaction. Acids such as HCl, HNO3, and HCN that contain one ionizable hydrogen atom in each molecule are called monoprotic acids. Their reactions with water are: Monoprotic acids: Reactions with water HCl (aq) + H2O (l) ⟶ H3O+ (aq) + Cl− (aq) HNO3 (aq) + H2O (l) ⟶ H3O+ (aq) + NO3− (aq) HCN (aq) + H2O (l) ⇌ H3O+ (aq) + CN− (aq) Even though it contains four hydrogen...
02:08
Titration of a Polyprotic Acid
0 Views •
2020
A polyprotic acid contains more than one ionizable hydrogen and undergoes a stepwise ionization process. If the acid dissociation constants of the ionizable protons differ sufficiently from each other, then the titration curve for such polyprotic acid generates a distinct equivalence point for each of its ionizable hydrogens. Therefore, titration of a diprotic acid results in the formation of two equivalence points, whereas the titration of a triprotic acid results in the formation of three...
FAQs
After formation in activated platelets, thromboxane A2 binds thromboxane receptors and promotes additional platelet aggregation. At the same time, it contributes to vascular smooth muscle contraction, producing vasoconstriction. These coordinated effects strengthen hemostasis by helping platelets accumulate at an injury site, although excessive signaling can favor thrombus formation.
The pathway proceeds through sequential enzymatic steps. Cyclooxygenase converts arachidonic acid into prostaglandin H2, and thromboxane synthase then converts prostaglandin H2 into thromboxane A2. This order matters pharmacologically because interrupting cyclooxygenase activity prevents formation of the precursor required for downstream thromboxane production.
Rapid hydrolysis to thromboxane B2 limits how long the active signal persists. Thromboxane A2 can therefore produce prompt effects on platelets and vascular tone without remaining stable for prolonged periods. The conversion also provides a downstream product that reflects pathway activity, helping researchers distinguish the transient signaling molecule from its more stable breakdown product.
Its effects depend on the biological setting. At sites of cellular injury, platelet activation and vasoconstriction help support blood clot formation and limit bleeding. When the pathway contributes excessively to platelet activity or vascular constriction, however, the same mechanisms can promote pathological thrombosis and become relevant to cardiovascular disease.
Aspirin reduces thromboxane A2 production by inhibiting platelet cyclooxygenase, thereby limiting conversion of arachidonic acid toward the prostaglandin H2 intermediate. Reduced downstream signaling can lessen platelet aggregation and related vascular effects. This mechanism makes aspirin important in research on antiplatelet therapy and approaches to managing vascular risk.
The pathway connects a defined biochemical sequence with measurable physiological outcomes: platelet activation, aggregation, clot formation, and vascular tone. Pharmacology uses this connection to examine how reducing thromboxane production may alter thrombotic risk. It also provides subject-specific context for studying the balance between necessary hemostasis and cardiovascular disease associated with excessive clotting.